International Assets Investment Management LLC Acquires New Shares in Henry Schein, Inc. (NASDAQ:HSIC)

International Assets Investment Management LLC acquired a new stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 49,590 shares of the company’s stock, valued at approximately $3,754,000.

Several other hedge funds also recently modified their holdings of the company. Cambridge Investment Research Advisors Inc. lifted its holdings in Henry Schein by 2.4% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 5,262 shares of the company’s stock worth $459,000 after buying an additional 122 shares during the period. Aurora Investment Counsel lifted its holdings in Henry Schein by 0.7% during the 3rd quarter. Aurora Investment Counsel now owns 20,641 shares of the company’s stock worth $1,533,000 after buying an additional 140 shares during the period. Arizona State Retirement System lifted its holdings in Henry Schein by 0.4% during the 4th quarter. Arizona State Retirement System now owns 35,890 shares of the company’s stock worth $2,717,000 after buying an additional 149 shares during the period. Studio Investment Management LLC lifted its holdings in Henry Schein by 3.9% during the 4th quarter. Studio Investment Management LLC now owns 4,160 shares of the company’s stock worth $332,000 after buying an additional 155 shares during the period. Finally, Kentucky Retirement Systems Insurance Trust Fund lifted its holdings in Henry Schein by 3.4% during the 3rd quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 4,878 shares of the company’s stock worth $321,000 after buying an additional 161 shares during the period. Institutional investors and hedge funds own 96.62% of the company’s stock.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, CEO Bradford C. Connett sold 6,430 shares of Henry Schein stock in a transaction dated Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total transaction of $477,620.40. Following the completion of the transaction, the chief executive officer now owns 73,108 shares in the company, valued at approximately $5,430,462.24. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, Vice Chairman James P. Breslawski sold 2,907 shares of the business’s stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $74.37, for a total value of $216,193.59. Following the transaction, the insider now owns 209,562 shares in the company, valued at approximately $15,585,125.94. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Bradford C. Connett sold 6,430 shares of the business’s stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total value of $477,620.40. Following the completion of the transaction, the chief executive officer now owns 73,108 shares in the company, valued at approximately $5,430,462.24. The disclosure for this sale can be found here. Company insiders own 1.14% of the company’s stock.

Henry Schein Stock Performance

Shares of Henry Schein stock opened at $71.22 on Wednesday. Henry Schein, Inc. has a one year low of $60.01 and a one year high of $85.39. The firm has a market capitalization of $9.15 billion, a price-to-earnings ratio of 22.61, a PEG ratio of 1.76 and a beta of 0.87. The business has a 50-day simple moving average of $74.63 and a 200 day simple moving average of $72.52. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.67 and a quick ratio of 1.00.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, February 27th. The company reported $0.66 EPS for the quarter, missing analysts’ consensus estimates of $0.70 by ($0.04). Henry Schein had a net margin of 3.37% and a return on equity of 14.03%. The firm had revenue of $3.02 billion during the quarter, compared to the consensus estimate of $3 billion. During the same period in the previous year, the firm earned $1.21 earnings per share. The business’s quarterly revenue was down 10.5% on a year-over-year basis. On average, research analysts anticipate that Henry Schein, Inc. will post 5.07 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the company. TheStreet raised Henry Schein from a “c+” rating to a “b-” rating in a report on Monday, February 26th. SVB Leerink began coverage on Henry Schein in a research report on Monday, February 26th. They issued a “market perform” rating and a $78.00 price objective for the company. JPMorgan Chase & Co. lifted their price objective on Henry Schein from $82.00 to $88.00 and gave the stock an “overweight” rating in a research report on Wednesday, March 6th. Leerink Partnrs reissued a “market perform” rating on shares of Henry Schein in a research report on Monday, February 26th. Finally, Piper Sandler lifted their price objective on Henry Schein from $78.00 to $86.00 and gave the stock an “overweight” rating in a research report on Monday, February 26th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $81.09.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.